Objective Transsphenoidal surgery (TSS) is considered the treatment of choice in most
patients with growth hormone (GH)-secreting pituitary adenomas. Several preoperative …

Background The factors associated with initial and delayed remission after growth hormone
(GH)-secreting pituitary adenoma excision have not been completely elucidated. Methods …

BACKGROUND: Extensive data exist regarding the success rates and long-term outcomes
of transsphenoidal adenomectomy (TSA) of growth hormone (GH)-secreting pituitary tumors; …

Purpose Growth hormone-secreting pituitary adenomas (GH-PAs) with a low Knosp grade
are typically associated with a good postoperative biochemical remission (BR) rate …

Objective To determine the predictive factors for endocrinological remission of patients with
growth hormone (GH)-secreting pituitary adenomas. Methods In 47 patients with GH …

Objective Transsphenoid surgery is the treatment of choice for growth hormone (GH)-
producing pituitary adenomas. The measures that may predict postoperative remission need …

BACKGROUND: Transsphenoidal surgery is safe and effective in patients with secreting
pituitary adenomas; however, variable outcomes have been reported according to the …

Background Acromegaly is a rare, chronic disorder that mostly results from growth hormone
(GH)–secreting pituitary adenoma. Transsphenoidal surgery is the first-line treatment of this …

Objective and design A clinicopathological score has been proposed by Trouillas et al. to
predict the evolution of pituitary adenomas. Aim of our study was to perform an independent …

OBJECTIVE Transsphenoidal surgery is advocated as the first-line management of growth
hormone (GH)–secreting adenomas. Although disease control is defined by strict criteria for …